E

Envista Holdings Corp
NYSE:NVST

Watchlist Manager
Envista Holdings Corp
NYSE:NVST
Watchlist
Price: 25.94 USD 0.15% Market Closed
Market Cap: $4.3B

P/E

90.4
Current
321%
More Expensive
vs 3-y average of 21.5

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
90.4
=
Market Cap
$4.8B
/
Net Income
$47m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
90.4
=
Market Cap
$4.8B
/
Net Income
$47m

Valuation Scenarios

Envista Holdings Corp is trading above its 3-year average

If P/E returns to its 3-Year Average (21.5), the stock would be worth $6.16 (76% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-76%
Maximum Upside
No Upside Scenarios
Average Downside
74%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 90.4 $25.94
0%
3-Year Average 21.5 $6.16
-76%
5-Year Average 22.2 $6.38
-75%
Industry Average 27.6 $7.92
-69%
Country Average 22.9 $6.56
-75%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
$4.8B
/
Jan 2026
$47m
=
90.4
Current
$4.8B
/
Dec 2026
$234.4m
=
20.7
Forward
$4.8B
/
Dec 2027
$259.2m
=
18.7
Forward
$4.8B
/
Dec 2028
$286.3m
=
16.9
Forward
$4.8B
/
Dec 2029
$313.4m
=
15.5
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Market Distribution

Higher than 91% of companies in the United States of America
Percentile
91st
Based on 8 489 companies
91st percentile
90.4
Low
0 — 15.3
Typical Range
15.3 — 33.2
High
33.2 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 15.3
Median 22.9
70th Percentile 33.2
Max 1 826 183.3

Envista Holdings Corp
Glance View

Market Cap
4.3B USD
Industry
Health Care

Envista Holdings Corp., a prominent player in the dental industry, spins a captivating narrative of innovation and expertise. Emerging from a legacy rooted in the exceptional engineering standards of Danaher Corporation, Envista was formed to focus sharply on dental products and solutions. Its operational structure is divided into three main segments: Specialty Products & Technologies, Orthodontic Products, and Equipment & Consumables. With a strategic emphasis on orthodontics and endodontics, the company engineers advanced technological solutions such as clear aligners, imaging software, and digital treatment planning tools. This specialization is key to its operations, allowing Envista to cater to dental practitioners' diverse needs with products that boost the efficiency and precision of dental treatments. Revenue generation for Envista hinges upon its broad portfolio of trusted brands, including KaVo Kerr, Nobel Biocare, and Ormco, which are synonymous with quality in the dental field. Through these brands, Envista not only manufactures and sells premium dental equipment and supplies, but also provides comprehensive services from maintenance and repair to educational support. The company utilizes a robust distribution network and partners with dental service organizations globally, ensuring its products reach a wide audience. Furthermore, Envista’s commitment to research and development fuels its profitability by continually offering state-of-the-art solutions that meet the evolving demands of the dental industry. This relentless focus on innovation and customer-centric approaches underpin its financial performance, positioning Envista as a formidable force in its market.

NVST Intrinsic Value
28.65 USD
Undervaluation 9%
Intrinsic Value
Price $25.94
E
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett